Whole Slide Image Pipelines
Ingesting, tiling, storing, and serving gigapixel images with acceptable viewing and processing performance, which is substantial infrastructure work before any analysis occurs.
AI pathology engineers build systems that analyze digitized tissue slides. They handle whole slide image pipelines at gigapixel scale, stain and scanner variation, region annotation workflows, and quantification support, working so a pathologist reviews and issues every diagnostic interpretation.
Digital pathology carries a data problem before it carries a modeling problem. A single slide can exceed several gigabytes, a case may contain dozens, and staining varies between batches, laboratories, and scanners in ways that shift model behavior substantially. Teams that underestimate the infrastructure spend their budget on storage and throughput. Taction Software scopes that first, and our hire dedicated developers hub covers adjacent roles.

Our experts are ready to understand your business goals.






























































Applications range from operational support that carries modest regulatory weight to quantification that enters diagnostic reports. The work below spans that range. Quality control and workflow applications appear prominently because they deliver value while a laboratory is still building digital capability, and because they do not require the validation burden that interpretation support carries.
Ingesting, tiling, storing, and serving gigapixel images with acceptable viewing and processing performance, which is substantial infrastructure work before any analysis occurs.
Detecting focus problems, tissue folds, insufficient sample, and staining defects so slides can be rescanned or recut before a pathologist wastes time on them.
Highlighting tissue regions for pathologist attention within large slides, reducing the search burden without asserting what the regions contain.
Counting, measuring, and scoring where the task is enumerative rather than interpretive, with results presented for pathologist verification and adjustment.
Building annotation environments usable at slide scale, with guidelines and agreement measurement, since annotation cost dominates most pathology AI programs.
Organizing slides, prior cases, and clinical context for review, and routing cases based on operational rather than diagnostic criteria.
Pathology introduces variation absent from radiology. Tissue processing, staining protocols, section thickness, and scanner characteristics all affect image appearance, and each varies by laboratory and over time. A model trained on one laboratory’s slides frequently degrades on another’s for reasons unrelated to the biology. The context below spans the healthcare work you assign and determines whether a program generalizes at all.
Stain intensity and hue differ by batch, protocol, and laboratory. Normalization and augmentation are required rather than optional, and validation must span this variation.
Fixation time, processing, and section thickness change morphology. Models can learn laboratory processing signatures rather than tissue characteristics without careful validation.
Different scanners produce different color profiles and resolution characteristics. Validation across scanner types is required before deployment beyond the development site.
Pathologist annotation at slide scale is costly, and inter-observer agreement on many tasks is genuinely limited. Reported performance cannot exceed label quality.
Pathologists integrate multiple slides, clinical history, and ancillary studies. Region-level model output is one input rather than an interpretation of the case.
Systems highlight, count, and measure. Diagnostic interpretation, grading, and the report are the pathologist’s, and no output substitutes for that determination.
This work is heavily weighted toward data engineering. Handling gigapixel images efficiently, normalizing stain variation, and building annotation tooling that pathologists tolerate consume most of the effort. The competencies below reflect that. Weight image pipeline engineering and stain normalization above model architecture, because throughput and generalization are the constraints that determine whether anything reaches use.
Working with proprietary slide formats, pyramidal tiling, efficient storage, and serving architecture that supports both interactive viewing and batch processing at scale.
Applying normalization and color augmentation so models tolerate the staining variation present across batches, laboratories, and time within a single institution.
Choosing tile size and magnification, and aggregating tile-level output to region or slide level, where aggregation choices substantially affect reported performance.
Building or configuring slide-scale annotation with guidelines, adjudication, and inter-observer agreement measured rather than assumed across annotating pathologists.
Connecting to laboratory information systems and scanner output. Our healthcare integration work covers the connectivity these workflows require.
Evaluating on slides from other laboratories and scanners, with performance reported by source, since single-site validation overstates transferability substantially.
The distinguishing question is what happened on slides from another laboratory. Engineers who have tested this describe stain-driven degradation specifically. Those who have not will present single-site metrics as general performance. Our assessment centers on pipeline engineering, normalization practice, and annotation rigor. Our delivery process includes review points for reassessing fit.
We ask what happened on external slides. Candidates who never tested this have not confronted the generalization problem that defines digital pathology.
We ask how they handled staining variation. Engineers without a specific approach built models that learned laboratory signatures rather than tissue characteristics.
We ask what inter-observer agreement they measured. Unmeasured agreement means reported performance may exceed the reliability of the labels themselves.
We ask how they handled slide volume and size. Engineers who worked only with small extracted patches have not built production-scale infrastructure.
We ask how tile output became slide-level results. Aggregation choices materially affect performance, and candidates unaware of that have not examined their own pipeline.
We describe which pathology systems each engineer built and what reached laboratory use. We do not claim pathology credentials for engineers who lack them.
Engagements should confirm digital infrastructure readiness before scoping analysis, because many laboratories are still building scanning capacity and storage. Analysis without reliable digitization has nothing to run on. Structures below reflect that. We also recommend quality control applications first, since they deliver value during digitization buildout and require far less validation than interpretation support.
Assessing scanning capacity, storage, throughput, and slide availability. Analysis projects fail when digitization cannot supply consistent images at volume.
Slide quality screening delivers operational value immediately, requires modest validation, and builds pipeline capability the laboratory needs regardless of later analysis work.
Suits one bounded application with allocated pathologist annotation time. Annotation availability, not engineering capacity, determines what is achievable.
Where you own validation strategy, staff augmentation adds engineering capacity working within your existing quality system and annotation practices.
A dedicated healthcare development team suits programs spanning pipelines, annotation infrastructure, analysis, laboratory integration, and validation.
Where the requirement is slide infrastructure rather than analysis, a fixed-scope build under our engagement models delivers ingestion, storage, and serving capability.
Share your scanner types, slide volumes, storage capacity, and pathologist annotation availability. Infrastructure readiness determines feasibility before any analysis question.
Pathology output can approach diagnostic territory quickly. Where intended use may create diagnostic or treatment claims, SaMD classification is assessed during discovery. Taction holds no FDA clearance for your product and guarantees no regulatory outcome. IEC 62304 applies to medical device software lifecycle processes where applicable. We build to HIPAA-aligned practices where HIPAA applies; software cannot be HIPAA certified.
Performance is established on slides from other laboratories and scanners. Single-site validation does not support deployment given the extent of preanalytic and staining variation.
Systems highlight regions, count, and measure. Diagnostic interpretation, grading, and reporting remain the pathologist’s, and no output is presented as a diagnostic conclusion.
Where morphology or biomarker expression differs across populations, validation examines that. Unexplained disparity blocks deployment rather than appearing as a limitation note.
Counts and measurements are shown with the regions they derive from, so a pathologist can confirm or adjust rather than accepting a number without provenance.
Slide labels frequently carry patient identifiers in the image itself. De-identification must address label regions and metadata rather than metadata alone.
We would not build systems that issue diagnoses, grade specimens without pathologist confirmation, sign out cases, or remove slides from pathologist review.
Cost concentrates in image infrastructure and annotation. Storage and throughput for gigapixel images are substantial ongoing expenses, and pathologist annotation time is the expensive input that determines achievable performance. We publish no figures on accuracy, concordance, or turnaround, because those depend on your laboratory, scanners, and case mix. What we deliver is validation documentation on your own slides.
$40,000 to $80,000
One bounded application with available annotated slides, typically quality control screening or a defined quantification task with internal validation and laboratory workflow integration.
$80,000 to $200,000
Digital pathology capability with slide pipelines, annotation infrastructure, analysis, cross-scanner validation, laboratory system integration, and monitoring.
Starting at $200,000
Multi-laboratory deployment with validation across sites and scanners, quality system documentation, and lifecycle management. Cost scales with laboratories and validation depth.
Discovery is paid and time-boxed. It produces an infrastructure readiness assessment, slide and annotation availability review, intended use and classification finding, and an itemized fixed-scope estimate.
Scanner variety, slide volume and storage requirements, annotation volume and pathologist availability, stain variation across sources, laboratory system integration, and validation breadth.
Storage and compute for whole slide images are continuing costs. Budget also for revalidation as scanners and protocols change, annotation refresh, and pipeline maintenance.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Where regulated work such as validation or a federal authorization pathway applies, that scope is priced separately from engineering.
Two questions matter. Whether the vendor validates across scanners and laboratories, and whether they will confirm infrastructure readiness before scoping analysis. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age. Our wider case for Taction sits elsewhere.
We built Revive Ease and PainKare, both FDA-registered applications. That work informs how we treat intended use and documentation where analysis approaches diagnostic claims.
Pathology AI depends on laboratory connectivity. Our healthcare case studies reflect integration experience across clinical and diagnostic systems.
We built Voyant Health, an EHR platform. Understanding how results reach clinicians determines how pathology output should be delivered and recorded.
Taction Software holds ISO 27001 certification covering our information security management practices. It certifies our internal processes and does not determine your organization’s compliance position.
Storage and throughput for whole slide imaging are substantial and often underestimated. We state those costs before you commit rather than surfacing them mid-project.
Slide quality screening delivers value during digitization buildout with modest validation burden. That recommendation defers the interpretation project and reduces near-term scope.
We review your scanning capacity, storage, slide availability, and pathologist annotation time, then present candidates with pathology imaging experience. You interview and approve each engineer.
One application runs $40,000 to $80,000, a full platform $80,000 to $200,000, and multi-laboratory deployment starts at $200,000. Storage, compute, and licensing are itemized separately and are substantial.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
Stain intensity and hue vary by batch, protocol, laboratory, and scanner. Models can learn those signatures rather than tissue characteristics, which is why cross-site validation is mandatory.
No. It highlights regions, counts, and measures for pathologist verification. Diagnostic interpretation, grading, and sign-out remain the pathologist’s determination in every case.
That page covers radiology and pathology interpretation support broadly. This page addresses whole slide imaging specifically, where gigapixel infrastructure and stain variation dominate the engineering.
Share your scanner types and volumes, storage capacity, slide availability, pathologist annotation time, intended use, and the engagement model you have in mind. We will assess infrastructure readiness first and state plainly what the storage and validation burden implies. We do not promise instant matching or any performance figure.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.